|
WO2020237302A1
|
|
Wireless electrochemical analysis
|
|
WO2020227775A1
|
|
Systems and methods for analyte determination
|
|
WO2020113271A1
|
|
Methods of diagnosing a disease state
|
|
WO2020110069A1
|
|
Microscopy method and system
|
|
WO2020110072A1
|
|
Automated method of identifying a structure
|
|
WO2020110070A1
|
|
Method of identifying a structure
|
|
WO2020110071A1
|
|
Method of identifying a structure
|
|
WO2020073097A1
|
|
Substituted heterocyclic inhibitors of lysine biosynthesis via the diaminopimelate pathway
|
|
AU2019323944A1
|
|
Compositions and methods for reducing bacterial aggregation
|
|
WO2019241851A1
|
|
Inhibitors of lysine biosynthesis via the diaminopimelate pathway
|
|
WO2019241850A1
|
|
Substituted sulfonyl hydrazides as inhibitors of lysine biosynthesis via the diaminopimelate pathway
|
|
WO2019144183A1
|
|
Biomarkers of colorectal cancer
|
|
CN111051964A
|
|
Image contrast enhancement for optical microscopy
|
|
CA3059422A1
|
|
Heterocyclic inhibitors of lysine biosynthesis via the diaminopimelate pathway
|
|
WO2018049476A1
|
|
Determining complex refractive index values of a sample in three dimensions
|
|
AU2017234382A1
|
|
Mobile voltammetric analysis
|
|
AU2017217248A1
|
|
Method of diagnosis
|
|
EP3298145A1
|
|
Method of diagnosis of breast cancer
|
|
US2017335004A1
|
|
FN14-binding proteins and uses thereof
|
|
AU2014203658A1
|
|
FN14 binding proteins and uses thereof
|
